SMRT reported another set of poor results in 1QFY14 with profits plunging 55% YoY (S$16m). Heavy staff and repair expenses continued to take their toll. SMRT had reported its first-ever loss in 4QFY13.
 
Macquarie Equities Research analyst: Somesh Kumar Agarwal

400mrtSMRT's 1Q profit plunged 55% YoY to S$16 m. NextInsight file photo Bleeding will continue; Investors have to accept the new normal: SMRT has become half the profitable firm that it used to be. From generating profit in the range of S$160m annually until FY11, the business can now generate only half the profits in our view.

 Train business is hardly making money due to additional staff and repair expenses: MRT business EBIT margin fell to only 1.8% in the quarter. Last quarter it was 0.5%.
 
 Bus business has been bleeding for long; No solution seems to be in sight: Bus business has now reported an operating loss for 11 consecutive quarters. With no fare revisions possible, this business is becoming more and more unsustainable.
 
 Rental and advertising businesses save the day: The non-core businesses have generated all the profit that SMRT is making now.
 
 The new reality is that SMRT is only an S$90-110m profit business: And even all of this profit would be delivered by its non-core business of “rental and advertisement”. Its core businesses – Rail, Bus and Taxi – will hardly make any profit in our view.

Earnings and target price revision 
 Reducing earnings by 21% and 15% each for FY14 and FY15. Reducing target price to S$0.99 cents from S$1.13 earlier. 

Action and recommendation
 At 24x FY14 P/E, the stock deserves a sharp de-rating: With no growth in sight, ROEs plunging to ~10% levels from ~22% in the past, the stock deserves to trade at a much lower multiple in our view. Even on P/B, the stock is expensive at 2.5x FY14E. The company is not even a high dividend payer anymore with hardly any profits left to distribute. We do not see more than 2-3% dividend yield on the stock going forward.
 


mrt.chart8.13SMRT's stock has been on a decline in the past year and could have further downside. Chart: Bloomberg

Nomura Equity Research analyst: Wen Jie Chan 

Catalyst: Earnings surprise on the downside
 
We think the stock could continue to de-rate if earnings continue to surprise on the downside, which are likely to come mainly from a further deterioration of the core business. We also don’t rule out further impairment losses on SMRT’s investment in Shenzhen Zona or its Singapore bus business.
 
Another de-rating catalyst would be a further reduction in dividends to potentially zero, in our view. Our FY14F earnings/dividend forecasts are 45%/70% below consensus.
 
Valuation/Risks 
The stock currently trades at 38.5/39.1x FY14F/FY15F P/E (EPS: 3.72c/3.65c), which is beyond the high end of its trading range. We estimate SMRT will offer a FY14F dividend yield of 0.7% on our revised dividend estimates.
 
Key upside risks include higher average fares and passenger growth; higher-than-expected subsidies/grants; better cost control; regulatory changes; and better performance at its associate and engineering division. 

Valuation: 
We continue to value the stock on a DCF basis, on which we derive our new TP of SGD1.16, representing a 14% cut from our previous TP. We assume a cost of equity of 6.2% and a terminal growth rate of 2%, and cash flows are discounted back to endFY13F. We cut our TP on the back of our lower earnings forecasts. 
 

Comments  

0 #1 Mardi 2013-08-01 17:59
Analyst recommendation are based on past data. Fare revision soon will get approval. If gov do not allow fare increment. .privatisation will be an option. Current price is very cheap. Can slowly accumulate.
Quote

Share Prices

Counter NameLastChange
AEM Holdings4.0000.040
Avi-Tech Electronics0.275-0.005
Broadway Ind0.141-
China Sunsine0.4500.010
DISA0.003-
Food Empire0.500-0.005
Fortress Minerals0.3500.010
Geo Energy Res0.3650.010
Golden Energy0.7950.045
GSS Energy0.050-
InnoTek0.4400.005
ISDN Holdings0.430-
ISOTeam0.104-
IX Biopharma0.131-0.001
Jiutian Chemical0.0770.001
KSH Holdings0.335-
Leader Env0.050-
Medtecs Intl0.109-0.001
Meta Health0.0300.003
Moya Asia0.0890.001
Nordic Group0.490-
Oxley Holdings0.159-0.001
REX International0.225-
Riverstone0.5750.010
Sinostar PEC0.180-
Southern Alliance Mining0.630-
Straco Corp.0.410-
Sunpower Group0.260-
The Trendlines0.083-
Totm Technologies0.1230.001
UG Healthcare0.168-0.001
Uni-Asia Group0.860-0.030
Wilmar Intl3.840-0.020
Yangzijiang Shipbldg1.0300.010

NextInsight RSS

rss_2 NextInsight - Latest News

Online Now

We have 225 guests and no members online